Home/Filings/4/0001209191-19-021441
4//SEC Filing

Porter Derrell 4

Accession 0001209191-19-021441

CIK 0001604464other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 5:17 PM ET

Size

4.9 KB

Accession

0001209191-19-021441

Insider Transaction Report

Form 4
Period: 2019-03-26
Porter Derrell
SVP, Head of Global Commercial
Transactions
  • Award

    Common Stock

    2019-03-26+10,00031,688 total
Footnotes (1)
  • [F1]These restricted stock units vest as to 50% of the shares on March 26, 2020 and 50% of the shares on March 26, 2021, subject to the reporting person's continuous service.

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001706400

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:17 PM ET
Size
4.9 KB